BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes

Hazem El-Osta; Gerald Falchook; Apostolia Tsimberidou; David Hong; Aung Naing; Kevin Kim; Sijin Wen; Filip Janku; Razelle Kurzrock

doi:10.1371/journal.pone.0025806

Loading metrics

Open Access

Peer-reviewed

Research Article

BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes

Hazem El-Osta,

Affiliation Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
⨯
Gerald Falchook,

Affiliation Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
⨯
Apostolia Tsimberidou,

Affiliation Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
⨯
David Hong,

Affiliation Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
⨯
Aung Naing,

Affiliation Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
⨯
Kevin Kim,

Affiliation Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
⨯
Sijin Wen,

Affiliation Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
⨯
Filip Janku,

Affiliation Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
⨯
Razelle Kurzrock

* E-mail: rkurzroc@mdanderson.org

Affiliation Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
⨯

BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes

Hazem El-Osta,
Gerald Falchook,
Apostolia Tsimberidou,
David Hong,
Aung Naing,
Kevin Kim,
Sijin Wen,
Filip Janku,
Razelle Kurzrock

Published: October 19, 2011
https://doi.org/10.1371/journal.pone.0025806

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Thyroid carcinoma
Is the Subject Area "Thyroid carcinoma" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Melanoma
Is the Subject Area "Melanoma" applicable to this article?

Thanks for your feedback.
Brain metastasis
Is the Subject Area "Brain metastasis" applicable to this article?

Thanks for your feedback.
Cancer detection and diagnosis
Is the Subject Area "Cancer detection and diagnosis" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.